Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2014 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Completes the Second Tranche of the $35 Million Convertible Debt Financing With Deerfield Management Company

GAITHERSBURG, Md., June 26, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, today announced receipt, following satisfaction of...
May 15, 2014 16:15 ET | Source: Cytomedix, Inc.

Cytomedix Reports 2014 First Quarter Financial Results

GAITHERSBURG, Md., May 15, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, today reported financial results for the three...
May 08, 2014 09:42 ET | Source: Cytomedix, Inc.

Cytomedix to Host First Quarter 2014 Financial Results Conference Call on Friday, May 16, 2014

GAITHERSBURG, Md., May 8, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, announced today that it will release financial...
May 05, 2014 16:15 ET | Source: Cytomedix, Inc.

Cytomedix Announces Results of RECOVER-Stroke Phase 2 Study; Provides Update on R&D Reorganization and Ongoing Launch Initiatives for AutoloGel(TM)

Results from RECOVER-Stroke Phase 2 Trial Show No Significant Clinical Benefit; Completion of R&D Restructuring Expected to Lead to Additional Cost Savings; Continued Strategic Focus on...
April 22, 2014 16:00 ET | Source: Cytomedix, Inc.

Cytomedix Announces Two AutoloGel(R) Presentations at the Symposium on Advanced Wound Care (SAWC) Spring Meeting

GAITHERSBURG, Md., April 22, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, today announced two key oral presentations and a...
April 07, 2014 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Announces Appointment of Andrew Cohen as Vice President of Marketing

GAITHERSBURG, Md., April 7, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, announced today the appointment of Andrew Cohen as...
April 03, 2014 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Announces Receipt of USPTO Allowance for Patent Covering Use of ALDH Bright Cells in Stroke

GAITHERSBURG, Md., April 3, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, and its wholly owned subsidiary, Aldagen, Inc.,...
March 31, 2014 16:30 ET | Source: Cytomedix, Inc.

Cytomedix Reports 2013 Fourth Quarter and Full Year Financial Results; Announces Up to $35 Million Convertible Debt Financing With Deerfield Management Company

$2 Million Additional Equity Investment with Anson Group Conference Call Scheduled for Tuesday, April 1st at 8:00 AM Eastern Time GAITHERSBURG, Md., March 31, 2014 (GLOBE NEWSWIRE) --...
March 31, 2014 16:30 ET | Source: Cytomedix, Inc.

Cytomedix Announces Senior Management Appointments

Industry Veteran and Wound Care Commercial Expert Dean Tozer Appointed as Executive Vice President and Chief Commercial Officer Jennifer Linsky Appointed as Senior Director of National Accounts...
March 25, 2014 08:00 ET | Source: Cytomedix, Inc.

Cytomedix to Host Fourth Quarter & Fiscal Year End 2013 Financial Results Conference Call on Tuesday, April 1, 2014

GAITHERSBURG, Md., March 25, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, announced today that it will release financial...